--yep, I've got all of those on my
various watch lists. It is a pretty
simple system, as I get increasingly
interested in a stock, it migrates upward
until it arrives on my primary watch list,
a list of about a dozen stocks. Unfortunately
I'm not as discriminating as others would be,
and lots of interesting things, to me, float
to the top. I'll let you in a decade or two
when I've got this figured out. Thanks very
much for your comments--they always give
me new ideas for rooting around, now I can
go dig up Cheresh abstracts...and I still haven't
done my DD on Del-1, always plenty of stuff
further scrutinize as you say.
Thread: While I'm here, I found this last night
on the upenn/IHGT website, one of the Spring
Seminars--this one would be for anybody who
follows Onyx. A person might be able to get
ahold of somebody at Onyx and get a copy of
the presentation maybe (??) --I don't know if
they would do that for you, but worth a try.
March 22 - Monday
Frank McCormick, Ph.D. F.R.S.
Professor of Microbiology & Immunology
Director, Cancer Center & Cancer Research Institute
University of California San Francisco
"Cancer Therapy Based on p53 Tumor Suppressor"
4:00 - 5:00 P.M.
Reception prior to seminar, 3:30 - 4:00 pm.
Robert Austrian Auditorium
Clinical Research Building, University of Pennsylvania
med.upenn.edu |
